Plasma phospholipid saturated fatty acids and incident atrial fibrillation: The Cardiovascular health study

Journal of the American Heart Association

Volumn 3, Issue 3, 2014, Pages

  Fretts, Amanda M ^b   Mozaffarian, Dariush ^e,f   Siscovick, David S ^a,b   Djousse, Luc ^e   Heckbert, Susan R ^b   King, Irena B ^d   McKnight, Barbara ^b   Sitlani, Colleen ^a   Sacks, Frank M ^e   Song, Xiaoling ^c   Sotoodehnia, Nona ^a   Spiegelman, Donna ^e   Wallace, Erin R ^b   Lemaitre, Rozenn N ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c USA   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f TUFTS UNIVERSITY   (United States)

Author keywords

Atrial fibrillation; Epidemiology; Fatty acid

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ARACHIDIC ACID; BEHENIC ACID; LIGNOCERIC ACID; PALMITIC ACID; PHOSPHOLIPID; SATURATED FATTY ACID; STEARIC ACID; FATTY ACID; STEARIC ACID DERIVATIVE;

AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMMUNITY SAMPLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; ATRIAL FIBRILLATION; BLOOD; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; EICOSANOIC ACIDS; FATTY ACIDS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PALMITIC ACID; PHOSPHOLIPIDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STEARIC ACIDS; UNITED STATES;

EID: 84920684482     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.000889     Document Type: Article

References (50)

1. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104:1534-1539.
2. Magnani JW, Rienstra M, Lin H, Sinner MF, Lubitz SA, McManus DD, Dupuis J, Ellinor PT, Benjamin EJ. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation. 2011;124:1982-1993.
3. Thacker EL, McKnight B, Psaty BM, Longstreth WT Jr, Sitlani CM, Dublin S, Arnold AM, Fitzpatrick AL, Gottesman RF, Heckbert SR. Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology. 2013;81:119-125.
4. Wu JH, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, Heckbert SR, Siscovick DS, Mozaffarian D. Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the Cardiovascular Health Study. Circulation. 2012;125:1084-1093.
5. Fretts AM, Mozaffarian D, Siscovick DS, Heckbert SR, McKnight B, King IB, Rimm EB, Psaty BM, Sacks FM, Song X, Spiegelman D, Lemaitre RN. Associations of plasma phospholipid and dietary alpha linolenic acid with incident atrial fibrillation in older adults: the Cardiovascular Health Study. J Am Heart Assoc. 2014;3:e000889 doi: 10.1161/JAHA.114.000889.
6. Hudgins LC, Hellerstein M, Seidman C, Neese R, Diakun J, Hirsch J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest. 1996;97:2081-2091.
7. Knopp RH, Retzlaff B, Walden C, Fish B, Buck B, McCann B. One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects. Proc Soc Exp Biol Med. 2000;225:191-199.
8. King IB, Lemaitre RN, Kestin M. Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. Am J Clin Nutr. 2006;83:227-236.
9. Simon JA, Fong J, Bernert JT Jr, Browner WS. Relation of smoking and alcohol consumption to serum fatty acids. Am J Epidemiol. 1996;144:325-334.
10. Siler SQ, Neese RA, Hellerstein MK. De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. Am J Clin Nutr. 1999;70:928-936.
11. Wu JHY, Lemaitre RN, Imamura F, King IB, Song XL, Spiegelman D, Siscovick DS, Mozaffarian D. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study. Am J Clin Nutr. 2011;94:431-438.
12. Yli-Jama P, Meyer HE, Ringstad J, Pedersen JI. Serum free fatty acid pattern and risk of myocardial infarction: a case-control study. J Intern Med. 2002; 251:19-28.
13. Simon JA, Fong J, Bernert JT Jr. Serum fatty acids and blood pressure. Hypertension. 1996;27:303-307.
14. Matsumoto C, Hanson NQ, Tsai MY, Glynn RJ, Gaziano JM, Djousse L. Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians' Health Study. Clin Nutr. 2013;32:819-823.
15. Grimsgaard S, Bonaa KH, Jacobsen BK, Bjerve KS. Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension. 1999;34:478-483.
16. Zheng ZJ, Folsom AR, Ma J, Arnett DK, McGovern PG, Eckfeldt JH. Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 1999;150:492-500.
17. Lemaitre RN, King IB, Sotoodehnia N, Knopp RH, Mozaffarian D, McKnight B, Rea TD, Rice K, Friedlander Y, Lumley TS, Raghunathan TE, Copass MK, Siscovick DS. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism. 2010;59:1029-1034.
18. Kang JX, Xiao YF, Leaf A. Free, long-chain, polyunsaturated fatty-acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA. 1995;92:3997-4001.
19. Xiao YF, Gomez AM, Morgan JP, Lederer WJ, Leaf A. Suppression of voltagegated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA. 1997;94:4182-4187.
20. Leifert WR, McMurchie EJ, Saint DA. Inhibition of cardiac sodium currents in adult rat myocytes by n-3 polyunsaturated fatty acids. J Physiol. 1999; 520:671-679.
21. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary D, Psaty BM, Rautaharju PM, Tracy RP, Weiler P. The cardiovascular health study: design and rationale. Ann Epidemiol. 1991;1:263-276.
22. Kumanyika SK, Tell GS, Shemanski L, Martel J, Chinchilli VM. Dietary assessment using a picture-sort approach. Am J Clin Nutr. 1997;65:1123S-1129S.
23. Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc. 1993;93: 790-796.
24. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509.
25. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a onestep reaction. J Lipid Res. 1986;27:114-120.
26. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. N-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 2003;77:319-325.
27. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455-2461.
28. Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles MF, Lefkowitz D, Siscovick DS. Fish intake and risk of incident atrial fibrillation. Circulation. 2004;110:368-373.
29. Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol. 2003;91:9G-14G.
30. Menezes AR, Lavie CJ, DiNicolantonio JJ, O'Keefe J, Morin DP, Khatib S, Milani RV. Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc. 2013;88:394-409.
31. Flock MR, Kris-Etherton PM. Diverse physiological effects of long-chain saturated fatty acids: implications for cardiovascular disease. Curr Opin Clin Nutr Metab Care. 2013;16:133-140.
32. Fuhrman BJ, Barba M, Krogh V, Micheli A, Pala V, Lauria R, Chajes V, Riboli E, Sieri S, Berrino F, Muti P. Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab. 2006;50:95-102.
33. Chong MF, Hodson L, Bickerton AS, Roberts R, Neville M, Karpe F, Frayn KN, Fielding BA. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding. Am J Clin Nutr. 2008;87:817-823.
34. Hu FB, Stampfer MJ, Manson JE, Ascherio A, Colditz GA, Speizer FE, Hennekens CH, Willett WC. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr. 1999;70:1001-1008.
35. Krisetherton PM, Mustad VA. Chocolate feeding studies-a novel-approach for evaluating the plasma-lipid effects of stearic-acid. Am J Clin Nutr. 1994;60: S1029-S1036.
36. Tholstrup T. Influence of stearic acid on hemostatic risk factors in humans. Lipids. 2005;40:1229-1235.
37. Jakobsson A, Westerberg R, Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res. 2006;45:237-249.
38. Schwab US, Maliranta HM, Sarkkinen ES, Savolainen MJ, Kesaniemi YA, Uusitupa MI. Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesteryl ester transfer protein activity in healthy young women. Metabolism. 1996;45:143-149.
39. Guillou H, Zadravec D, Martin PG, Jacobsson A. The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice. Prog Lipid Res. 2010;49:186-199.
40. Kihara A. Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem. 2012;152:387-395.
41. Lee YG, Lee J, Cho JY. Cell-permeable ceramides act as novel regulators of U937 cell-cell adhesion mediated by CD29, CD98, and CD147. Immunobiology. 2010;215:294-303.
42. Ussher JR, Koves TR, Cadete VJ, Zhang L, Jaswal JS, Swyrd SJ, Lopaschuk DG, Proctor SD, Keung W, Muoio DM, Lopaschuk GD. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes. 2010;59:2453-2464.
43. Grosch S, Schiffmann S, Geisslinger G. Chain length-specific properties of ceramides. Prog Lipid Res. 2012;51:50-62.
44. Crowder CM. Cell biology. Ceramides-friend or foe in hypoxia? Science. 2009;324:343-344.
45. Kim NH, Ahn Y, Oh SK, Cho JK, Park HW, Kim YS, Hong MH, Nam KI, Park WJ, Jeong MH, Ahn BH, Choi JB, Kook H, Park JC, Jeong JW, Kang JC. Altered patterns of gene expression in response to chronic atrial fibrillation. Int Heart J. 2005;46:383-395.
46. Aime-Sempe C, Folliguet T, Rucker-Martin C, Krajewska M, Krajewski S, Heimburger M, Aubier M, Mercadier JJ, Reed JC, Hatem SN. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol. 1999;34:1577-1586.
47. Heinke MY, Yao M, Chang D, Einstein R, dos Remedios CG. Apoptosis of ventricular and atrial myocytes from pacing-induced canine heart failure. Cardiovasc Res. 2001;49:127-134.
48. Osmancik P, Peroutka Z, Budera P, Herman D, Stros P, Straka Z, Vondrak K. Decreased apoptosis following successful ablation of atrial fibrillation. Cardiology. 2010;116:302-307.
49. Li Y, Gong ZH, Sheng L, Gong YT, Tan XY, Li WM, Dong DL, Yang BF, Fu SB, Xue HJ. Anti-apoptotic effects of a calpain inhibitor on cardiomyocytes in a canine rapid atrial fibrillation model. Cardiovasc Drugs Ther. 2009;23:361-368.
50. Trappe K, Thomas D, Bikou O, Kelemen K, Lugenbiel P, Voss F, Becker R, Katus HA, Bauer A. Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study. Eur Heart J. 2013;34:147-157.